Belmont Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $471K | Hold |
19,441
| – | – | 0.07% | 75 |
|
|
2025
Q1 | $493K | Buy |
19,441
+8,141
| +72% | +$206K | 0.09% | 66 |
|
|
2024
Q4 | $300K | Buy |
11,300
+1,957
| +21% | +$51.9K | 0.05% | 66 |
|
|
2024
Q3 | $270K | Sell |
9,343
-41,354
| -82% | -$1.2M | 0.04% | 102 |
|
|
2024
Q2 | $1.42M | Buy |
50,697
+8,539
| +20% | +$239K | 0.26% | 33 |
|
|
2024
Q1 | $1.17M | Hold |
42,158
| – | – | 0.32% | 33 |
|
|
2023
Q4 | $1.21M | Buy |
42,158
+26,728
| +173% | +$770K | 0.52% | 26 |
|
|
2023
Q3 | $512K | Buy |
15,430
+1
| +0% | +$33 | 0.28% | 37 |
|
|
2023
Q2 | $566K | Buy |
15,429
+143
| +0.9% | +$5.25K | 0.32% | 32 |
|
|
2023
Q1 | $624K | Sell |
15,286
-609
| -4% | -$24.8K | 0.52% | 19 |
|
|
2022
Q4 | $814K | Hold |
15,895
| – | – | 0.87% | 14 |
|
|
2022
Q3 | $696K | Buy |
+15,895
| New | +$696K | 0.82% | 11 |
|